Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia

Leukemia

Volumn 10, Issue 8, 1996, Pages 1269-1273

  Hasle, H ^a,c   Kerndrup, C ^a   Yssing, M ^b   Clausen, N ^c   Ostergaard E ^d   Jacobsen, N ^b   Jacobsen, B Brock ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b University of Copenhagen   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute myeloid leukemia; Bone marrow transplantation; Chemotherapy; Juvenile chronic myeloid leukemia; Myelodysplastic syndrome

Indexed keywords

CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; MITOXANTRONE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; COMPARATIVE STUDY; CYTOPENIA; FEMALE; HUMAN; INFANT; INTRATHECAL DRUG ADMINISTRATION; LEUKEMIA REMISSION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

EID: 0029743347     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin C, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
2. Hann IM. Myelodysplastic syndromes. Arch Dis Child 1992; 67: 962-966.
3. Hasle H. Myelodysplastic syndromes in childhood. Classification, epidemiology, and treatment. Leuk Lymphoma 1994; 13: 11-26.
4. Hasle H, Kerndrup G, Jacobsen BB. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. Leukemia 1995; 9: 1569-1572.
5. Hann IM. Disorders of the blood and reticuloendothelial system. In: Campbell AGM, McIntosh N (eds). Forlar and Arneil's Textbood of Paediatrics. Churchill Livingstone: Edinburgh, 1992, pp 919-954.
6. Creutzig U, Cantù-Rajnoldi A, Ritter J, Romitti L, Odenwald E, Conter V, Riehm H, Masera G. Myelodysplastic syndromes in childhood. Report of 21 patients from Italy and West Germany. Am J Pediatr Hematol Oncol 1987; 9: 324-330.
7. Weiss K, Stass S, Williams D, Kalwinsky D, Dahl GV, Wang W, Johnson FL, Murphy SB, Dow LW. Childhood monosomy 7 syndrome: clinical and in vitro studies. Leukemia 1987; 1: 97-104.
8. Brandwein JM, Horsman DE, Eaves AC, Eaves CJ, Massing BG, Wadsworth LD, Rogers PC, Kalousek DK. Childhood myelodysplasia: suggested classification as myelodysplastic syndromes based on laboratory and clinical findings. Am J Pediatr Hematol Oncol 1990; 12: 63-70.
9. Festa RS, Shende A, Lanzkowsky P. Juvenile chronic myelocytic leukemia: experience with intensive combination chemotherapy. Med Pediatr Oncol 1990; 18: 311-316.
10. Lie SO, Berglund G, Gustafsson G, Jonmundsson G, Siimes M, Yssing Y. High-dose Ara-C as a single-agent consolidation therapy in childhood acute myelogenous leukemia. Hamatol Bluttransfus 1990; 33: 215-221.
11. Passmore SJ, Hann IM, Stiller CA, Ramami P, Swansbury GJ, Gibbons B, Reeves BR, Chessells JM. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood 1995; 85: 1742-1750.
12. Anderson JE, Appelbaum FR, Fisher LD, Schoch G, Shulman H, Anasetti C, Bensinger WI, Bryant E, Buckner CD, Doney K, Martin PJ, Sanders JE, Sullivan KM, Thomas ED, Witherspoon RP, Hansen JA, Storb R. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 1993; 82: 677-681.
13. Locatelli F, Pession A, Bonetti F, Maserati E, Prete L, Pedrazzoli P, Zecca M, Prete A, Paolucci P, Cazzola M. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Leukemia 1994; 8: 844-849.
14. Donadieu J, Stephan JL, Blanche S, Cavazzana Calvo M, Baruchel A, Herbelin C, Benkerrou M, Thomas C, Girault D, Fischer A. Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation. Bone Marrow Transplant 1994, 13: 777-782.
15. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-625.
16. Castleberry RP, Freedman MH, Baruchel A, Biondi A, Castro-Malaspina H, Hasle H, Miyauchi J, Niemeyer C, Passmore SJ, Shannon K, Emanuel PD. Juvenile chronic myelogenous leukemia revisited. A report of the first meeting of the international juvenile myelomonocytic leukemia working group. Br J Haematol (Submitted).
17. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983; 54: 431-440.
18. Woods WG, Nesbit ME, Buckley J, Lampkin BC, McCreadie S, Kim TH, Piomelli S, Kersy JH, Feig S, Bernstein I, Hammond D the Children's Cancer Study Group. Correlation of chromosome abnormalities with patient characteristics, histologic subtype, and induction success in children with acute nonlymphocytic leukemia. J Clin Oncol 1985; 3: 3-11.
19. Kalwinsky DK, Raimondi SC, Schell MJ, Mirro JJ, Santana VM, Behm F, Dahl GV, Williams D. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J Clin Oncol 1990; 8: 75-83.
20. Estey EH, Keating MJ, Dixon DO, Trujillo JM, McCredie KB, Freireich EJ. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia. Hematol Pathol 1987; 1: 203-208.
21. Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol 1995; 13: 1800-1816.
22. Chan CCF, Wang W, Raimondi S, Behm F, Krance R, Head D. Distinction of AML with low blast count from pediatric MDS is clinically important. Blood 1994; 84: 315a (Asbtr.).
23. Xue Y, Yu F, Zhou Z, Guo Y, Xie X, Lin B. Translocation (8;21) in oligoblastic leukemia: is this a true myelodysplastic syndrome? Leuk Res 1994; 18: 761-765.
24. Fenaux P, Morel P, Rose C, Lai JL, Jouet JP, Bauters F. Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy. Br J Haematol 1991; 77: 497-501.
25. de Witte T, Muus P, De Pauw B, Haanen C. Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia. Cancer 1990; 66: 831-837.
26. Gajewski JL, Ho WG, Nimer SD, Hirji KF, Gekelman L, Jacobs AD, Champlin RE. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome. J Clin Oncol 1989; 7: 1637-1645.
27. Ganser A, Heil G, Kolbe K, Maschmeyer G, Fischer JT, Bergmann L, Mitrou PS, Heit W, Heimpel H, Huber C, Hoelzer D. Aggressive chemotherapy combined with G-CSF and maintenance therapy with interleukin-2 for patients with advanced myelodysplastic syndrome, subacute or secondary acute myeloid leukemia - initial results. Ann Hematol 1993; 66: 123-125.
28. Bernell P, Kimby E, Hast R. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in acute myeloid leukemia evolving from myelodysplastic syndromes: a pilot study. Leukemia 1994; 8: 1631-1639.
29. de Witte T, Zwaan F, Hermans J, Vernant J, Kolb H, Vossen J, Lönnqvist B, Beelen D, Ferrant A, Gmür J, Lie Yin J, Troussard X, Cahn J, Van Lint M, Gratwohl A. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). Br J Haematol 1990; 74: 151-155.
30. Sutton L, Leblond V, Le Maignan C, Jouet JP, Kuentz M, Gluckman E, Biaise D, Marit G, Attal M, Troussard X, Bordigoni P, Cahn JY, Ribaud P. Bone marrow transplantation for myelodsyplastic syndrome and secondary leukemia: outcome of 86 patients. Bone Marrow Transplant 1991; 7 (Suppl 2): 39.
31. List AF, Garewal HS, Sardberg AA. The myelodysplastic syndromes: biology and implications for management. J Clin Oncol 1990; 8: 1424-1441.
32. Tefferi A, Thibodeau SN, Solberg LA. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood 1990; 75: 1770-1773.
33. Nylund SJ, Verbeek W, Larramendy ML, Ruutu T, Heinonen K, Hallman H, Knuutila S. Cell lineage involvement in four patients with myelodysplstic syndrome and 1(1;7) or trisomy 8 studied by simultaneous immunophenotyping and fluorescence in situ hybridization. Cancer Genet Cytogenet 1993; 70: 120-124.
34. Weimar IS, Bourhis JH, De Gast GC, Gerritsen WR. Clonality in myelodysplastic syndromes. Leuk Lymphoma 1994; 13: 215-221.
35. Busque L, Gilliland DG, Prchal JT, Sieff CA, Weinstein HJ, Sokol JM, Belickova M, Wayne AS, Zuckerman KS, Sokol L, Castleberry RP, Emanuel PD. Clonality in juvenile chronic myelogenous leukemia. Blood 1995; 85: 21-30.
36. Smith FO, Raskind WH, Fialkow PJ, Bernstein ID. Cellular biology of acute myelogenous leukemia. J Pediatr Hematol Oncol 1995; 17: 113-122.
37. Estrov Z, Dube ID, Chan HSL, Freedman MH. Residual juvenile chronic myelogenous leukemia cells detected in peripheral blood during clinical remission. Blood 1987; 70: 1466-1469.
38. Smith FO, Raskind WH, Waldron P, Steinmann LJ, Matsushita M, Singer JW, Lampkin BC, Woods WG, Lange BJ, Hammond GD, Fialkow PJ, Bernstein ID. Clonal remission in childhood acute myeloid leukemia is an infrequent event. Leukemia 1993; 7: 929-932.